Skip to main content

Generics

  • Aurobindo’s hypertension and diabetes generics earn FDA approval

    EAST WINDSOR, N.J. — The Food and Drug Administration granted final approval for Aurobindo Pharma’s amlodipine and olmesartan medoxomil Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg. The Division of Bioequivalence has determined Aurobindo's Amlodipine and olmesartan medoxomil Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Azor of Daiichi Sankyo.

  • NCPA submits comments on Medicare, drug access to House committee

    ALEXANDRIA, Va. — The National Community Pharmacy on Monday submitted its comments to the House Ways and Means Health Subcommittee, suggesting how to improve access to prescription drugs and essential health services for Medicare beneficiaries. The organization, writing on behalf of the roughly 22,000 independent community pharmacy owners, highlighted pharmacy’s role in facilitating patient healthcare access.

  • FDA approves Lupin’s Seroquel XR generic

    SILVER SPRING, Md. — The Food and Drug Administration on Thursday approved Lupin’s generic of AstraZeneca’s Zeroquel XR (quetiapine fumarate) extended-release tablets.

    The drug is indicated to treat schizophrenia, acute manic or mixed bipolar I disorder on its own or as an adjunctive treatment to lithium or divalproex, acute depressive disorders in bipolar disorder, maintenance treatment of bipolar I, as an adjunctive treatment to lithium or divalproex and as an adjunctive treatment to antidepressants for the treating major depressive disorder.

  • Meijer opens first upper peninsula stores

    GRAND RAPIDS, Mich. — Meijer on Thursday opened new supercenters in Escanaba and Sault Ste.

  • Analyst: An Amazon entry into the pharmacy business would not be ‘market disruptive’

    SEATTLE — A Wall Street analyst believes the potential for Amazon’s entry into the pharmacy business would not be “market disruptive.” These are the words of Mizuho Securities analyst Ann Hynes.

    According to Barron’s, a major reason for this line of thinking is that ordering drugs by mail is not a new innovation. “CVS and Walgreens have been in this business for years and have relationships with drug companies and insurers that give them an early advantage,” the newspaper wrote.

  • Express Scripts to lower generic costs through Walgreens Boots Alliance Development

    ST. LOUIS — Express Scripts, through its wholly-owned subsidiary Innovative Product Alignment, on Thursday announced it will participate in the Walgreens Boots Alliance Development group purchasing organization.

  • Amazon reportedly exploring pharmacy options

    NEW YORK — Amazon.com may be on the cusp of entering the pharmaceutical dispensing business, according to a report published by CNBC Tuesday. The company reportedly has hired a general manager whose role is said to be helping the online retailer explore how to hang a pharmacy shingle.

  • Consumer Reports research pinpoints reasons for rising drug prices

    NEW YORK — High-deductible insurance plans, changes to “your formulary,” and a few “extremely high-priced drugs” are the main culprits behind increasing drug prices, according to Consumer Reports data released Tuesday.

X
This ad will auto-close in 10 seconds